Work

A phase II study of BAY 43–9006 in patients with androgen-independent prostate cancer (AIPC) with proteomic profiling

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.4762

Authors: E. M. Posadas, J. Gulley, P. M. Arlen, N. Harold, S. Fioravanti, P. Meltzer, C. D. Scripture, W. D. Figg, E. C. Kohn, W. L. Dahut

Institutions: National Human Genome Research Institute, National Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589335595

Cites:

Cited by: 3

Related to: 10